SCHEMBL20152070

SCHEMBL20152070

CC(C)(C)N1CCC(NC(=O)c2ncccc2Cl)C1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
SSTR4 P31391 5/20 0.46
WNT1 P04628 1/20 0.45
DYRK1A Q13627 1/20 0.45
RET P07949 1/20 0.45
PDE4B Q07343 2/20 0.42
KDM5A P29375 1/20 0.42
SSTR1 P30872 2/20 0.42
USP30 Q70CQ3 2/20 0.42
GRM5 P41594 1/20 0.41
ELANE P08246 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
CNR2 P34972 1/20 0.40
TRPV1 Q8NER1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20147609 0.86 KDM5A (0.56) SSTR4WNT1DYRK1ARETPDE4B
SCHEMBL20068949 0.85 SSTR4 (0.51) MEN1KMT2ASSTR4KDM5ASSTR1
SCHEMBL20147608 0.82 HRH3 (0.52) MEN1KMT2AWNT1DYRK1AKDM5A
SCHEMBL20158754 0.82 RET (0.45) SSTR4RETALDH1A1CNR2
SCHEMBL24665402 0.75 TAS1R3 (0.50) MEN1KMT2ASSTR4SSTR1ALDH1A1
SCHEMBL10282562 0.75 CHRNA7 (0.56) MEN1KMT2AKDM5AKDM4EALDH1A1
SCHEMBL20201377 0.74 CTSL (0.60) MEN1KMT2AUSP30ALDH1A1
SCHEMBL22652448 0.74 CTSL (0.60) MEN1KMT2AUSP30ALDH1A1
SCHEMBL20068971 0.73 RET (0.46) MEN1KMT2ASSTR4RETSSTR1
SCHEMBL20068980 0.72 RET (0.47) SSTR4RETSSTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180148445-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-31 US disclosed
US-20180148445-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-31 US disclosed
US-20180134703-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148445-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, BRAF, RAF1 MEN1 653/4885KMT2A 1112/4885SSTR4 2604/4885
US-20180134703-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, BRAF, RAF1 MEN1 653/4885KMT2A 1112/4885SSTR4 2604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.